BioSpace - Astralis, Ltd. News, Search Jobs, Events

Biotech and Pharmaceutical
News & Jobs

Search the Site

Employers
Post Job | Search Resumes | Login

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

Company Profile

Astralis, Ltd.

75 Passaic Avenue

Fairfield New Jersey 07004 U.S.A.
Phone: 973-227-7168 Fax: 973-227-7169

Industry
Biotechnology
Services

Collaborations
University of Pennsylvania Medical Center Dr. James Leyden, Professor of Dermatology University of Pennsylvania Hospital, Philadelphia, PA, Chairman of Medical Advisory Board of Astralis.
Texas Dermatology Research Institute Dr. William Abramovits, Professor of Dermatology Baylor Medical School, Dallas Texas, Principal Investigator of Clinical Trials
Rockefeller University Dr. James Krueger, Head of Laboratory for Investigative Dermatology and Associate Professor at Rockefeller University, New York, New York, Evaluation of Psoraxine's(tm) Mechanism of Action

Company News

Astralis, Ltd. (ASTR) Reports Third Quarter 2006 Results 11/21/2006 2:07:04 PM More...

Astralis, Ltd. (ASTR) Reviewing Strategic Alternatives And Change Of Status Of Officer; Considering Selling Assets Of The Company 10/9/2006 10:57:48 AM More...

Astralis, Ltd. (ASTR) Reports Second Quarter 2006 Results 8/22/2006 10:28:29 AM More...

Astralis, Ltd. (ASTR) Reports First Quarter 2006 Results 5/23/2006 10:39:40 AM More...

Astralis, Ltd. (ASTR) Reports 2005 Results 4/24/2006 11:12:20 AM More...

Astralis, Ltd. (ASTR) Reports 2004 Results 10/19/2005 5:13:11 PM More...

Astralis, Ltd. (ASTR) Phase II Study Of Psoraxine For Psoriasis Does Not Meet Primary Study Endpoint 10/19/2005 5:13:00 PM More...

Astralis, Ltd. (ASTR) Appoints Mr. James Sharpe As CEO 10/19/2005 5:12:44 PM More...

SkyePharma Inc. (SKYE) Intends To Increase Equity Stake In Astralis, Ltd. (ASTR) 10/19/2005 5:12:28 PM More...

Astralis, Ltd. (ASTR) Reports Third Quarter And Nine Month 2004 Results 10/19/2005 5:12:15 PM More...